• Phare
  • Validé par KD/KO

Anticorps Recombinant de lapin anti-Stathmin 1

Stathmin 1 Recombinant Antibody for WB, IHC, IF/ICC, IF-P, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF/ICC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

2H6

N° de cat : 82559-1-PBS

Synonymes

STMN1, 2H6, C1orf215, LAP18, Leukemia-associated phosphoprotein p18



Informations sur le produit

82559-1-PBS cible Stathmin 1 dans les applications de WB, IHC, IF/ICC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène Stathmin 1 Protéine recombinante Ag1633
Nom complet stathmin 1/oncoprotein 18
Masse moléculaire calculée 18 kDa
Poids moléculaire observé 18 kDa
Numéro d’acquisition GenBankBC014353
Symbole du gène Stathmin 1
Identification du gène (NCBI) 3925
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

Stathmin 1 (STMN1) normally regulates microtubule dynamics either by sequestering free tubulin heterodimers or by promoting microtubule catastrophe. STMN1 is highly expressed in fetal and adult brain, spinal cord, and cerebellum. Many different phosphorylated forms are observed depending on specific combinations among the sites which can be phosphorylated. Phosphorylation of stathmin is involved in response to NGF, neuron polarization and microtubule polymerization inhibition activity. Increased expression of STMN1 has been observed in a variety of human malignancies, such as colorectal primary tumors and metastatic tissues, but its association with melanoma is so far not well known.

{{ptg:RelatedPrimaryAntibodies}}